Management of infertility
AssigneeApplied Research Systems ARS Holding N.V.
InventorsBruno Lunenfeld, Yeheskel Menashe
Life of this patent
Estimating the term…
Abstract
A method for determining whether an infertile patient is likely to benefit from combined GH/gonadotropin or GHRH/gonadotropin therapy comprising the steps of (1) administering a predetermined dose of clonidine or a pharmaceutically acceptable derivative thereof to the patient; (2) monitoring the blood level of GH following the administration of clonidine or a derivative thereof; and (3) detecting whether the peak blood level of GH is above a predetermined level.
Claims9
A method for detecting whether an infertile female patient is likely to benefit from combined human growth hormone (GH) gonadotropin or growth hormone releasing hormone (GHRH) gonadotropin therapy which comprises administering a predetermined dose of clonidine or a pharmaceutically acceptable derivative thereof to said patient;
- monitoring the blood level of GH following administration of said clonidine or derivative thereof;
- and detecting whether the peak blood level of GH is above a predetermined minimum value.
Dependencies are inferred from the claim text.